Client Context
A Boston-based innovator in AI-powered digital pathology, had developed a groundbreaking research platform, SAINT, with the potential to revolutionize cancer research. To realize its global ambitions, the company targeted the MENA region for expansion. However, entering this complex healthcare ecosystem required more than just a cutting-edge product; it demanded deep local relationships and strategic government engagement.
Challenge
Secure hospital partnerships, build government trust, and integrate cardiologists and pathologists in its AI platform
ECG Intervention
- Brokered partnerships with leading cancer hospitals in UAE, KSA, Jordan, and Egypt.
- Secured government endorsements and Ministry of Health collaborations to integrate MENA genome data.
- Structured commercial agreements accelerating deployment across hospitals
Impact
- The client became a regional leader in AI-driven pathology.
- Enabled accelerated R&D and MENA-specific genomic enrichment, strengthening competitive advantage.
- Achieved market entry in 12 months vs. industry norm of 24+ months